达瑞生物 (832705.OC)

+ 收藏

现金流量表(达瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 93,714,298.18300,021,356.13134,731,206.71363,510,739.19190,051,672.82
 收到的税费返还(元) ---676,038.1536,546.66
 收到其他与经营活动有关的现金(元) 27,258,577.9011,880,573.339,466,664.8214,264,847.857,138,886.98
 经营活动现金流入小计(元) 120,972,876.08311,901,929.46144,197,871.53378,451,625.19197,227,106.46
 购买商品、接受劳务支付的现金(元) 53,823,931.48122,302,266.7476,738,024.18215,320,713.23115,381,061.36
 支付给职工以及为职工支付的现金(元) 37,611,255.5494,032,022.5162,138,778.35112,680,121.4867,241,837.79
 支付的各项税费(元) 2,623,118.9615,129,196.6812,043,903.2912,832,767.696,468,510.84
 支付其他与经营活动有关的现金(元) 8,446,903.7426,973,426.3515,478,957.3326,127,370.8414,039,859.07
 经营活动现金流出小计(元) 102,505,209.72258,436,912.28166,399,663.15366,960,973.24203,131,269.06
 经营活动产生的现金流量净额(元) 18,467,666.3653,465,017.18-22,201,791.6211,490,651.95-5,904,162.60
二、投资活动产生的现金流量
 收回投资收到的现金(元) 101,574,582.26441,073,814.36264,803,814.36506,002,663.11111,002,663.11
 取得投资收益收到的现金(元) 202,083.341,189,277.77614,333.312,722,983.511,199,963.14
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -178,628.00200.001,370.00-
 投资活动现金流入小计(元) 101,776,665.60442,441,720.13265,418,347.67508,727,016.62112,202,626.25
 购建固定资产、无形资产和其他长期资产支付的现金(元) 4,692,959.6824,491,528.459,606,686.3839,534,159.6715,848,100.94
 投资支付的现金(元) 110,000,000.00480,000,000.00315,000,000.00496,000,000.00191,000,000.00
 支付其他与投资活动有关的现金(元) -106,715,166.65---
 投资活动现金流出小计(元) 114,692,959.68611,206,695.10324,606,686.38535,534,159.67206,848,100.94
 投资活动产生的现金流量净额(元) -12,916,294.08-168,764,974.97-59,188,338.71-26,807,143.05-94,645,474.69
三、筹资活动产生的现金流量
 偿还债务支付的现金(元) ---25,000,000.0025,000,000.00
 分配股利、利润或偿付利息支付的现金(元) -368,626.61-23,726,932.3023,463,532.60
 支付其他与筹资活动有关的现金(元) -2,705,452.07-2,148,138.25-
 筹资活动现金流出小计(元) -3,074,078.68-50,875,070.5548,463,532.60
 筹资活动产生的现金流量净额(元) --3,074,078.68--50,875,070.55-48,463,532.60
四、汇率变动对现金及现金等价物的影响(元) 57,273.52117,194.60325,163.40898,254.56451,827.26
五、现金及现金等价物净增加额(元) 5,608,645.80-118,256,841.87-81,064,966.93-65,293,307.09-148,561,342.63
 加:期初现金及现金等价物余额(元) 158,340,274.59276,597,116.46276,606,516.46341,890,423.55341,890,423.55
 期末现金及现金等价物余额(元) 163,948,920.39158,340,274.59195,541,549.53276,597,116.46193,329,080.92
补充资料:
 净利润(元) 3,176,667.45-84,737,772.15-15,511,919.5020,269,395.4515,980,998.72
 资产减值准备(元) 302,223.7232,040,378.67-16,761,479.69-
 固定资产和投资性房地产折旧(元) 6,229,895.8813,388,140.466,746,006.1718,789,549.018,730,757.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 6,229,895.8813,388,140.466,746,006.1718,789,549.018,730,757.62
 无形资产摊销(元) 7,981,882.3016,706,926.677,077,671.0210,354,999.574,809,218.98
 长期待摊费用摊销(元) 885,806.742,328,879.341,127,071.903,566,494.141,663,543.26
 处置固定资产、无形资产和其他长期资产的损失(元) -95,354.76---
 固定资产报废损失(元) 427,622.391,533,372.55-81,036.68-
 公允价值变动损失(元) 328,555.935,824,592.53-2,377,077.84-159,844.59
 财务费用(元) 352,075.19368,626.61-1,070,859.58414,191.40-1,761,972.00
 投资损失(元) -1,526,871.53-839,649.823,822,791.654,030,964.202,376,652.97
 递延所得税(元) 37,595.3118,383,709.28-5,604,757.44-6,747,551.38-92,842.05
  其中:递延所得税资产减少(元) 86,878.7017,737,625.02-5,604,757.44-6,747,551.38-92,842.05
 递延所得税负债增加(元) -49,283.39646,084.26---
 存货的减少(元) -12,596,535.6618,211,778.185,861,697.84-8,358,112.00-7,748,443.89
 经营性应收项目的减少(元) -5,325,896.3398,423,889.3228,690,241.18-109,951,822.59-45,626,238.84
 经营性应付项目的增加(元) 15,069,485.22-74,652,079.41-55,917,182.8356,762,631.4415,014,881.06
 现金的期末余额(元) 163,948,920.39158,340,274.59195,541,549.53276,597,116.46193,329,080.92
 减:现金的期初余额(元) 158,340,274.59276,597,116.46276,606,516.46341,890,423.55341,890,423.55
 现金及现金等价物的净增加额(元) 5,608,645.80-118,256,841.87-81,064,966.93-65,293,307.09-148,561,342.63
公告日期 2024-08-302024-03-292023-08-302023-03-302022-08-29
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院